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Abstract
Background: The cardinal feature of osteoarthritis (OA) is pain. Although heterogeneity in pain and function have been
demonstrated in the long-term course of OA, the more proximate determinants of acute flare-ups remain less clear. How short-term
intermittent or transient exposures trigger acute flare-ups has important implications for effective and sustainable self-management
strategies.
Objective: The primary objective of this study is to identify potential triggers of acute flares in knee OA. Secondary objectives
are to determine their course and consequences and describe high-risk participant profiles.
Methods: We carried out a Web-based case-crossover study. This study aims to recruit 620 community-dwelling adults aged
≥40 years, resident in England, and who have knee pain, with or without a recorded diagnosis of knee OA, and no preexisting
diagnosis of inflammatory arthropathy. Participants will be recruited via 3 routes: (1) general practice registers, (2) offline
community advertisement, and (3) online social media advertisement. By using questionnaires comparing periods before participants’
self-reported flare-up episodes (hazard periods) with periods during the study when their knee OA symptoms are stable (control
periods), triggers preceding flare-ups will be identified and examined using conditional logistic regression. Time-to-resolution
of flare-up will be examined by monitoring people’s daily pain, bothersomeness, and medication usage until the participant reports
when their flare-up episode ends. Rates of flare-ups will be examined across different participant and flare characteristics using
regression models to identify high-risk participant profiles. A study-specific Patient Advisory Group (PAG) is providing suggestion,
input, and ongoing support for all stages of the research process.
Results: Participant recruitment opened in July 2018 and is anticipated to continue for 6 months. The study results will be
disseminated through a number of channels, including relevant national or international conferences and peer-reviewed publication
in a medical journal, via advocacy or charity organizations, such as Versus Arthritis and across social media. Findings will be
fed back to members of our PAG, study participants, and clinicians from participating primary care general practices. The PAG
will also take an active role in the overall dissemination strategy.
Conclusions: This study will provide empirical evidence to help patients identify common knee OA flare triggers and provide
health care professionals with questions to identify patients at most risk of frequent flare-ups.
International Registered Report Identifier (IRRID): DERR1-10.2196/13428
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Introduction
Pain caused by osteoarthritis (OA) is a major cause of functional
limitation and disability worldwide [1]. The course of OA pain
and functional limitation is heterogeneous among people [2-8],
and within different long-term trajectories, there is evidence of
substantial within-person variability over time. Shorter episodes
of more severe pain (acute flare-ups) deserve further
investigation for a number of reasons: (1) unpredictable episodes
of severe pain are distressing and disabling in themselves and
become more common in the late stages of OA [9], (2) they
may disrupt patterns of healthy behavior that serve to reduce
the risk of OA progression (eg, weight control, keeping active,
and reducing sedentary time) [10], and (3) episodic flare-ups
may herald (or may even cause) a transition to less favorable
long-term trajectory.
Evidence of short-term daily impact of flare-ups of knee pain
is emerging internationally [11,12] as are musculoskeletal
studies specifically demonstrating the utility of case-crossover
designs to examine transient physical and psychological triggers
of low back pain [13-15], knee OA [16-18], and hip OA [19].
Although flare-ups appear to be real phenomena experienced
by people with knee OA [11], the antecedents that cause
flare-ups and their consequences remain unclear. Our hypothesis
is that although susceptibility to flares may be determined by a
range of factors, they are ultimately triggered by short-term
exposures. The etiopathogenesis of OA is believed to reflect a
joint’s long-term attempt to accommodate or regulate cumulative
excessive or aberrant loading [20]. We postulate that intermittent
or transient activity–related exposures that precipitate short-lived
recurrent painful flare-ups are key to this process and related
management.
The primary objective of this study is to identify the most
common and consistently associated proximate causes (triggers)
of knee OA flares to help make acute flares more predictable
and therefore potentially preventable. Secondary objectives are
to
1. estimate the time course of acute flares in knee OA with
regard to symptoms, activities, and role interference to
provide better information to patients and practitioners on
the likely short-term prognosis.
2. determine whether characteristics of the participant and his
or her problem can identify individuals who are susceptible
to flares (frequent flare phenotypes) to target flare
management and preventive advice in practice.
Methods
Study Design
This study is a Web-based case-crossover study [21]. This
self-controlled design assembles within-person case-control
comparisons to establish if transient or intermittent exposures
(potential triggers) before acute or abrupt-onset events (knee
OA flare-up) may explain these episodes. Case-crossover
designs have been used to investigate triggers of acute-onset
disease (eg, myocardial infarction [22] and stroke [23]), health
care events (eg, [24,25]), and acute-on-chronic episodes (eg,
gout flares [26]). In this study, the case-crossover design was
chosen as an efficient method to identify recurrent
acute-on-chronic events [27], while capturing proximate
exposures. This design is particularly valuable in the context of
triggers of acute flares because it controls for time invariant
confounders, under the assumption that there are no time trends
in exposures over the period of investigation [28]. By conducting
this study using a Web-based platform, data collection is
efficient in terms of time and cost, while also enabling capture
of real-time information on recurrent flares [29].
Target Population
Community-dwelling adults aged 40 years and over, who are
resident in England, with knee pain and/or knee OA and have
daily access to email and the internet will be invited to take part
in this study. A full list of eligibility criteria is presented in
Table 1.
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Table 1. Eligibility criteria.
Mode of ascertainmentEligibility criteria
Inclusion criterion
GPSSa or registration pageMale or female aged ≥40 years, resident in England
GPSSRegistered as a permanent resident with participating general practicesb
GPSSConsultation for knee OA or knee OA-related joint symptoms in the last 2 yearsb,c
PCRFd or registration pageDaily access to an email account and to the internet (laptop, desktop, tablet, or smartphone)
Exclusion criterion
GPSS or registration pageKnown diagnosis of inflammatory arthropathy, spondyloarthropathy or crystal arthropathy (eg, rheumatoid arthritis,
ankylosing spondylitis, reactive arthritis, systemic lupus erythematosus, gout, and psoriatic arthritis), fibromyalgiac
GPSS or registration pageSymptoms are from a knee that has been replaced
GPSS or registration pageSurgery to either knee within the past 3 months
PCRF or registration pageUnable to complete questions written in English
GPSSVulnerable individuals (eg, psychiatric illness, learning difficulties, dementia, terminal illness, and severe enduring
mental ill health)b
aGPSS: General practice search and screen.
bApplicable only to participants recruited via general practices.
cBased on code lists (available upon request).
dPCRF: patient-completed reply form.
Recruitment Procedures
Recruitment will be done via 3 routes: (1) general practice
registers, (2) offline community advertisement, and (3) online
community advertisement.
General Practice Registers
In total, 5000 potentially eligible adults with suspected or
diagnosed clinical knee OA will be identified from up to 17
general practices across England and will be mailed a study
pack (letter of invitation, Participant Information Sheet (PIS),
reply form, and prepaid return envelope). General practitioners
at each practice will also be invited to screen the sample list for
patients whom they consider should be excluded from the
invitation mailing (eg, vulnerable individuals). A reminder letter,
together with a repeat PIS, reply form, and prepaid return
envelope, will be sent to people who have not responded after
2 weeks. People who have not responded within 4 weeks will
not be contacted again. Practice mailing will be performed in
stages.
Participants who return a reply form will be providing implied
consent to further contact. Those who, on their reply form, fulfill
the eligibility criteria and provide their name, a valid personal
email address, and mobile phone number (optional) will be sent
a preconsent welcome email containing a Web link to the
ACT-FLARE study website (developed using Microsoft Visual
Studio). The Web link will direct them to an online copy of the
PIS, and from there to the informed electronic consent
(e-consent) form. For people who return a reply form with
illegible, ambiguous, or invalid responses or personal details
(eg, invalid email address), an attempt to clarify this information
will be made with 1 follow-up email or letter, as appropriate,
asking the individual to contact the study team by phone or
email. If there is no response, these people will not be contacted
again.
Offline Community Advertisement
Study posters, flyers, or business card advertisements will be
displayed in the waiting areas and patient information points of
all participating general practices; additional general practices;
selected community pharmacies; patient waiting areas in
community hospitals; and public libraries across England, where
permission to do so is granted. Wherever possible, the study
will also be publicized through local newspapers and radio.
The advertising material will include the study title, summary
study information and eligibility, the Web address for the
ACT-FLARE study registration webpage, and study contact
email address and telephone number. Members of the public
who are interested in taking part and believe they may be eligible
will be invited to visit the ACT-FLARE study registration
webpage where summary information, eligibility, and contact
details are again displayed. Interested members of the public
who deem themselves eligible will be asked to submit key data
(implied confirmation of eligibility, email address, name
(optional), mobile phone number (optional), postcode (to ensure
they are an England resident), and how they heard about the
study) to Keele Clinical Trials Unit, which will generate a
unique study identification number and the preconsent welcome
email containing a Web link to the ACT-FLARE study website.
The Web link will direct them to a copy of the PIS and to the
informed e-consent process.
Online Community Advertisement
We will use targeted social media advertising in Facebook to
publicize the ACT-FLARE study. This will also include
placement of adverts on selected key organizational or group
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pages, such as Arthritis Research UK, Arthritis Care, Age UK,
and Patient UK, as well as Keele University Research Institute
for Primary Care & Health Sciences website, Facebook page,
Twitter account, and blog. Interested, potentially eligible
participants will be directed to the ACT-FLARE study
registration page where the same subsequent process of
recruitment as described in the offline route will be followed.
All participants will be invited to provide informed e-consent
before setting up a username and password for login access to
the ACT-FLARE study website to participate in the study.
Ethical approval has been obtained from Yorkshire & The
Humber—Leeds East Research Ethics Committee (REC
reference number: 18/YH/0075).
Data Collection
Data will be collected via self-complete questionnaires by the
participant using a Web-based data collection platform
previously developed as part of our feasibility and pilot study
[30]. All participants will be followed up for a 13-week period,
irrespective of how many flare-up episodes are experienced.
Data collection will comprise 4 elements: (1) baseline
questionnaire, (2) scheduled questionnaires, (3) event-driven
questionnaires, and (4) daily questionnaires during a flare-up.
Data collection has the following general features:
1. All questionnaires can be completed on a desktop, laptop,
tablet, or mobile smartphone in under 15 min, in accordance
with feedback from our Patient Advisory Group (PAG).
2. Questionnaires must be completed in one time point by the
participant. There is no facility for partial completion and
return at a later time. This approach was selected to ensure
that questionnaires are completed as contemporaneously
as possible.
3. Once a questionnaire has been completed and submitted by
a participant through the website, the participant no longer
has repeat access to the questionnaire.
4. A short onscreen thank you statement will be generated
following the completion of each questionnaire.
5. Remembering to notify the research team about a flare-up
has been identified as a critical issue. Participants who
provide a mobile telephone number (optional) will be sent
a reminder text message about the study once a fortnight
for the duration of the study. This will be calculated from
the date each participant completes their baseline
questionnaire, and all texts will be sent to participants at
18:00 Greenwich Mean Time.
6. At the end of the study, participants will be invited to
provide feedback on their participation in the study and
whether they would be willing to additionally participate
in clinical examinations during a knee flare-up, should a
similar study be conducted in the future, to include magnetic
resonance imaging and synovial fluid sample via knee joint
aspiration.
Baseline Questionnaire
The purpose of the baseline questionnaire is to provide
descriptive information on participants’ history of knee pain
and flare-ups, current knee features, health care use for knee
pain, general health, including normal physical activity
exposures, and demographics. The content of the baseline
questionnaire is provided in Table 2. It includes domains and
measurement instruments of potential relevance based on
previous literature and critical input from a PAG.
Once participants activate their log-in with the study website,
they will be directed to the baseline questionnaire, which
becomes available for completion immediately. At this point,
participants will also receive emailed instructions to use their
username and password to log-in to the website. If participants
do not complete the baseline questionnaire, an email reminder
will be sent after 3 days and a repeat email reminder after a
further 3 days. If no response is received after 7 days from the
initial date of invitation, participants can no longer continue in
the study. The participant will receive an email notification
confirming this.
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Section A: Your knee pain
Yes7 daysNot applicable, <1 year, 1-4 years, 5-9 years, 10+ years.
Left, right
Time since onset
Yes7 days5 flare pattern illustrations. Left, rightPattern [31]
Yes7 daysIn past 6 months: No pain, predictable pain, some unpre-
dictability, constant. Left, right
Experience of knee pain [32]
Yes7 daysNo days, few days, some days, most days, all days. Left,
right
Pain, aching, stiffness in last month [33,34]
Yes7 days0-10 Numerical Rating Scale with anchors (no pain, pain
as bad as you can imagine)
Worst and least in last week, average, current
[35]
Yes7 days7-items and 5-option categories for difficulties with daily
activities in last week
Knee injury and Osteoarthritis Outcome Score
Physical Function [36]
Yes7 days4-items and 5-option categories for quality of life in last
week
Knee injury and Osteoarthritis Outcome Score
Quality of Life [37]
Yes7 daysNot at all, slightly, moderately, very much, extremely. Left,
right
Bothersomeness in last 24 hours [38]
Yes7 daysYes, No. Left, rightFlare-up at present
Yes7 daysFree textSelf-reported main flare trigger
Yes7 daysVery bow legged, bow legged, normal, knock-knee, very
knock-knee. Left, right
Varus-valgus malalignment [39]
Yes7 daysVery turned out feet, turned out feet, straight, turned in
feet, very turned in feet. Left, right
Foot rotation [39]
Yes7 daysInjury induced walking problems for at least 1 week. Left,
right
Previous knee injury [40]
Yes7 daysMother, father, sister or brother. Yes, No, don’t knowFamily history of total knee replacement [40]
Section B: Health care use for your knee pain
Yes7 days17-option categories for drug use, tick as many boxes as
apply
Medications, last week
Yes7 daysGeneral practitioner, practice or district nurse, physiother-
apist, surgeon, rheumatologist, acupuncturist, occupational
therapist
Health professional consultation, last year
Yes7 daysYes, No. Left, rightAny kind of previous knee surgery
Yes7 daysLeft, right, both, not applicablePrevious knee injections last 3 months
Yes7 daysLeft, right, both, not applicablePrevious knee surgery last 3 months [40]
Yes7 daysLeft, right, both, not applicablePrevious total knee replacement
Yes7 daysLeft, right, both, not applicableOn waiting list for total knee replacement
Section C: Your general health
Yes7 daysExcellent, very good, good, fair, poorPerceived general health [41]
Yes7 daysWork physical activity (5-response options), general
physical activity in last week (5-response options, 4-option
categories), walking pace
Physical activity [42]
Yes7 daysStones and lbs or kgSelf-reported weight
Yes7 daysFeet and Inches or cmSelf-reported height
Normal physical activities on a normal day
Yes7 daysNot at all, A little, A lotWalking outside without rest
Yes7 daysNot at all, A little, A lotStanding for long periods without rest
Yes7 daysNot at all, A little, A lotSitting for long periods without a break
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Yes7 daysNot at all, A little, A lotModerate-to-vigorous physical activity (this
may include activities that make you breath
harder than normal) [43]
Yes7 daysNot at all, A little, A lotGoing up and down stairs
Yes7 daysNot at all, A little, A lotDriving
Yes7 daysNot at all, A little, A lotSquatting or kneeling
Yes7 daysNot at all, A little, A lotLifting or moving heavy objects
Yes7 daysNot at all, A little, A lotGoing up and down ladders
Section D: About you and your circumstances
Yes7 daysMale, femaleGender
Yes7 daysDate, Month, YearDate of birth
Yes7 daysPaid employment or self-employed, retired, looking after
home and/or family, unable to work because of sickness
or disability, unemployed, doing unpaid or voluntary work,
full or part-time student.
Current employment
Scheduled Questionnaires
The purpose of the scheduled questionnaires is to measure
activities and exposures (potential triggers) during control
periods (ie, days that are not followed by a flare-up). The content
for the scheduled questionnaire is provided in Table 3. It features
a matrix for reporting the occurrence and amount of 21 physical,
psychosocial, and environmental potential triggers on the day
of questionnaire completion and the 3 days before this. These
potential triggers have been selected from previous literature,
PAG discussion, and clinical experience.
In total, 4 scheduled questionnaires will be sent to participants
1 week, 5 weeks, 9 weeks, and 13 weeks after completion of
the baseline questionnaire. The timing of all scheduled
questionnaires remains the same in the event of delayed or
nonresponse to 1 or more scheduled questionnaires. All
participants will be sent an email inviting them to complete each
scheduled questionnaire about their activities and exposures
during the last 3 days. The email will contain a direct link to
the questionnaire, which will also become accessible at the
correct point in time should the participant log-in to the website
independently of the email link.
As a part of each scheduled questionnaire, participants will
initially be asked if they are currently experiencing a flare-up
of their knee pain. If no, they will continue to complete the
scheduled questionnaire. If yes, the participant will be redirected
to complete the event-driven questionnaire (see below).
Nonresponders will be sent an email reminder after 3 days and
a repeat email reminder after a further 3 days. If no response is
received after 7 days, the questionnaire becomes deactivated
and can no longer be completed. The participant will receive
an email notification confirming this. Nonrespondents to
scheduled questionnaires remain in the study.
Event-Driven Questionnaires
The purpose of the event-driven questionnaires is to measure
activities and exposures (potential triggers) during hazard
periods (ie, the 3 days before experiencing a flare-up) and to
gauge whether flare-ups are often anticipated by participants.
The content for the event-driven questionnaire is provided in
Table 4. As per the scheduled questionnaire, this features the
same matrix for reporting the occurrence and amount of 21
physical, psychosocial, and environmental potential triggers on
the day the flare-up started and the 3 days before this. In
addition, participants will be asked about features of their
flare-up.
Participants will be invited to complete an event-driven
questionnaire immediately if they provide notification through
the website that they are currently experiencing a self-reported
flare-up. This notification can be initiated either via a Web link
provided in the welcome email, scheduled questionnaire email,
text message correspondence, or by logging onto the study
website. There is no limit to the number of times a participant
can self-report a flare-up episode during the study period.
After providing a flare-up notification, if a participant does not
complete the event-driven questionnaire, an email reminder will
be sent after 1 day. A repeat email reminder will be sent after
a further day. If no response is received after 2 days, the
event-driven questionnaire becomes deactivated and can no
longer be completed. The participant will receive an email
notification confirming this. Nonrespondents to event-driven
questionnaires remain in the study.
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Yes7 daysYes, No. Left, rightFlare-up at present
Yes7 days0-10 Numerical Rating Scale with anchors
(no pain, pain as bad as you can imagine).
Left, right
Average pain in last 24 hours [44]
Potential triggers
Physical activities
Yes7 daysNot at all, A little, A lotWalking outside without rest
Yes7 daysNot at all, A little, A lotStanding for long periods without rest
Yes7 daysNot at all, A little, A lotSitting for long periods without a break
Yes7 daysNot at all, A little, A lotModerate-to-vigorous physical activity (this may include
activities that make you breath harder than normal) [43]
Yes7 daysNot at all, A little, A lotGoing up and down stairs
Yes7 daysNot at all, A little, A lotDriving
Yes7 daysNot at all, A little, A lotSquatting or kneeling
Yes7 daysNot at all, A little, A lotLifting or moving heavy objects
Yes7 daysNot at all, A little, A lotGoing up and down ladders
Slips, trips, sprains, and strains
Yes7 daysNo, YesSlip, trip or fall
Yes7 daysNo, YesEpisode of buckling or giving way [45]
Health and health care use
Yes7 daysNo, YesReduce or miss medication
Yes7 daysNo, YesTake extra medication
Yes7 daysNo, YesCough, cold, or other minor infection
Stress and other things
Yes7 daysNo, YesWork-related stress [46]
Yes7 daysNo, YesHome-related stress [46]
Yes7 daysNo, YesFriend/family-related stress [46]
Yes7 daysNo, YesLow mood/depression
Yes7 daysNo, YesFeeling angry, irritable, or hostile
Yes7 daysNo, YesPoor night’s sleep
Yes7 daysNo, YesGenerally cold and damp weather [47]
aQuestionnaire opens with orientation text: The following questions are about your knee symptoms at the moment. Please answer all questions below.
Some of these questions will ask you about things you may have been doing on the last 3 days. Please can you take a moment to remind yourself what
you were doing on each of these days to help you answer some of the questions below.
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Yes2 daysToday, yesterday, 2 days ago, 3 days
ago, 4 or more days ago
When did this flare-up start?
Yes2 daysYes, NoWas this flare-up unexpected?
Yes2 daysLeft, rightWhich knee currently experiencing a flare-up?
Yes2 days0-10 Numerical Rating Scale with
anchors (no pain, pain as bad as you
can imagine). Left, right
Average pain in last 24 hours [44]
Changes noticed since flare-up
Yes2 daysTick as many boxes as applyMore than usual: limping, swelling, stiffness, increased difficulty
with activities of daily living, sleep disturbance by knee pain
Potential triggers
Physical activities
Yes2 daysNot at all, A little, A lotWalking outside without rest
Yes2 daysNot at all, A little, A lotStanding for long periods without rest
Yes2 daysNot at all, A little, A lotSitting for long periods without a break
Yes2 daysNot at all, A little, A lotModerate-to-vigorous physical activity (this may include activities
that make you breath harder than normal) [43]
Yes2 daysNot at all, A little, A lotGoing up and down stairs
Yes2 daysNot at all, A little, A lotDriving
Yes2 daysNot at all, A little, A lotSquatting or kneeling
Yes2 daysNot at all, A little, A lotLifting or moving heavy objects
Yes2 daysNot at all, A little, A lotGoing up and down ladders
Slips, trips, sprains, and strains
Yes2 daysNo, YesSlip, trip, or fall
Yes2 daysNo, YesEpisode of buckling or giving way [45]
Health and health care use
Yes2 daysNo, YesReduce or miss medication
Yes2 daysNo, YesTake extra medication
Yes2 daysNo, YesCough, cold, or other minor infection
Stress and other things
Yes2 daysNo, YesWork-related stress [46]
Yes2 daysNo, YesHome-related stress [46]
Yes2 daysNo, YesFriend/family-related stress [46]
Yes2 daysNo, YesLow mood/depression
Yes2 daysNo, YesFeeling angry, irritable, or hostile
Yes2 daysNo, YesPoor night’s sleep
Yes2 daysNo, YesGenerally cold and damp weather [47]
Your flare-up
Yes2 daysFree textWhat do you think caused this flare-up of your knee pain?
aQuestionnaire opens with orientation text: The following questions are about your current flare-up of knee pain. Please answer all questions below.
Some of these questions will ask you about things you may have been doing on the 3 days before your flare-up and also on the day it started. Please can
you take a moment to remind yourself what you were doing on each of these days to help you answer some of the questions below.
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Daily Questionnaires During a Flare-Up
The purpose of the daily questionnaire during a flare-up is to
collect information regarding the natural course of flare-up
episodes. These comprise 4 brief questions on pain intensity,
bothersomeness, health care use, and participant judgment on
whether their flare-up has ended. The content for the daily
questions during flare-up is provided in Table 5.
Upon completion of the event-driven questionnaire, participants
will be invited to complete the 4 questions, starting one day
later, via email until resolution of their flare-up. Resolution is
defined as participants reporting that their symptoms have
returned to their preflare normal state for 2 consecutive days.
There will be no reminders for the daily questionnaires during
flare-up and participants can only complete questionnaires on
the day they are sent, with any earlier incomplete dates
becoming deactivated. Emails will be sent to participants at
18:00 Greenwich Mean Time for the duration of the flare-up
episode. Broderick et al [48] have previously demonstrated that
end-of-day pain measurement adequately reflects average daily
pain levels. If a participant is still reporting that they are in a
flare-up episode at the end of the study period, they will not be
followed up to flare-up resolution beyond this time point. If a
participant is having a flare-up, they will not receive a further
scheduled questionnaire until the participant notifies us that the
flare-up episode has resolved.





No6 hours0-10 Numerical Rating Scale with anchors (no pain, pain as bad as
you can imagine). Left, right
Average pain in last 24 hours [44]
Impact of pain
No6 hoursNot at all, slightly, moderately, very much, extremely. Left, rightBothersomeness in last 24 hours [38]
Medication use
No6 hoursNo; yes, but less than usual; yes, about the same as usual; yes, more
than usual
Pain medication taken in last 24 hours
Flare-up resolution
No6 hoursYes, NoHas your flare-up ended
Patient Involvement
This study is a patient-confirmed research priority, and a
study-specific PAG has assisted with the study development
from inception. So far, this has included advice and suggestion
on all aspects of questionnaire and website development as part
of this full-scale study and our previous feasibility and pilot
study [30]. Engagement has taken place through workshops,
written and verbal feedback on study questionnaires, and
practical hands-on trial of website utility during development.
One member of our PAG has remained an active member of
the study management group from inception (CP).
Outcome Definition
Self-reported flare-up of symptomatic knee OA is defined as
“an event in the natural course of the condition characterized
by a change in the participant’s baseline pain that is beyond
normal day-to-day variation, sustained for at least 24 hours, and
is sudden or quick in onset. It may impact on the ability to
perform everyday activities and result in an increase in analgesic
intake”. This definition was derived from our pilot study [30],
which used a qualitative approach based on self-assessment, a
previous literature review [49], group discussions with patients
and members of the public, and findings from a previous survey
and 3-month pen-and-paper daily diary study (unpublished data
at time of submission).
Sample Size
A sample size of 434 participants will have 80% power at a 5%
2-tailed significance level to detect an unadjusted odds ratio of
2 for knee pain flare-up in the hazard period relative to control
period if the probability of exposure (potential trigger) among
control periods is at least 0.1, the correlation coefficient for the
exposure between matched hazard periods and control periods
is no more than 0.3 [16], and assuming a 1:1 ratio of control
periods to hazard periods.
We will recruit 620 participants, allowing for approximately
30% of participants who may not experience a flare-up or
drop-out during the study period [16]. We estimate a total of
17 general practices will be required for this recruitment target.
This is based on 8% of adults aged ≥40 years consulting for
knee OA or knee joint pain over a 2-year period [50], an average
practice list size of 7000 patients, half of whom are aged ≥40
years, and a combined eligibility, response, and consent rate of
12%.
Recruitment of participants via offline and online community
advertisements will efficiently supplement the above recruitment
method, which will be particularly valuable in the event of
lower-than-expected participation and reported flare frequency,
and for reducing imprecision in important subgroup analyses,
for example, restricting analysis to participants who provide
early notification of flare-up and those whose flare-up proves
to be more than transient.
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Summary of Baseline Data and Flow of Participants
Recruitment and Retention
Production of a Consolidation Standards of Reporting
Trials–style participant flowchart and simple descriptive
statistics for response rates (including age, gender, and
deprivation score, derived from participant postcodes, of
responders compared with eligible nonresponders at baseline)
in accordance with standard definitions [51].
Summary Descriptive Characteristics of the Study Sample
Demographic and self-report clinical characteristics will be
described. Participants will be compared with ineligible and
nonconsenting participants on available data. Summary
descriptive characteristics of flare-ups, symptoms, and
consequences during the flare-up will be described.
Triggers, Course, Consequences, and High-Risk
Participant Profiles
Proximate Triggers of Acute Flares (Primary Objective)
The odds of identified potential flare-up antecedents or triggers
occurring in the hazard period will be compared with the relative
occurrence in the control period using conditional logistic
regression using m:n matching, as each participant may have
multiple hazard and control periods [52]. Modeled data will be
presented as odds ratios with 95% CIs. The assumption of no
time-trend in exposure will be verified.
The optimal duration of the hazard (effect) period for flare-ups
is unknown. Our primary analysis will be based on the scheduled
questionnaires (Weeks 1, 5, 9, and 13) being the main source
of control exposure measurements comparison for with the
event-driven questionnaire. The relative merits of hazard periods
of 24, 48, and 72 hours will be explored to test the induction
period, while also protecting the analysis against rare exposures.
In the advent of low levels of completion of the scheduled
questionnaire, we will explore alternative sources of control
measurement: (1) normal physical activity exposure
measurements ascertained in the baseline questionnaire and (2)
by exposure measurement in the preceding 48 and 72 hours (for
hazard period exposure defined in the preceding 24 hours) within
the event-driven questionnaire.
Owing to a lack of consensus definition for a flare-up in the OA
literature, our statistical analysis plan will allow for analysis of
alternative definitions, for example, no defined minimum
flare-up duration, or imposed knee pain change score of ≥2 on
a numerical rating scale, between baseline and self-reported
flare-up. We will also consider the potential for combining
related exposures.
By describing the proportion of triggers during the hazard
window that were reported by participants as being
unanticipated, the extent to which triggers were predictable will
be explored.
Time Course and Consequences of Acute Flares (Secondary
Objective 1)
Using the daily questionnaires during a flare-up,
time-to-resolution of symptoms will be compared across
participants.
Frequency of Acute Flares (Secondary Objective 2)
The rate of acute flares reported during follow-up will be
modeled using regression models. This will identify whether
certain participants and flare characteristics (collected in the
baseline questionnaires) are more or less likely to experience
flare-ups.
The amount of missing data will be calculated and the effects
on each of the analyses may be investigated using multiple
imputation.
Results
Participant recruitment opened in July 2018 and is anticipated
to continue for 6 months. The study results will be disseminated
through a number of channels, including relevant national or
international conferences and peer-reviewed publication in a
medical journal, via advocacy or charity organizations, such as
Versus Arthritis and across social media. Findings will be fed
back to members of our PAG, study participants, and clinicians
from participating primary care general practices. The PAG will
also take an active role in the overall dissemination strategy.
Discussion
Recognition of the potential importance of episodic flares in
the natural history of OA is gaining momentum among the
clinical research community [49,53,54]. In this 13-week
Web-based case-crossover study, we will combine general
practice–based recruitment with social media advertising across
England to identify proximate causes (triggers) of acute
flare-ups in knee OA, estimate their time course and
consequences, and describe individuals most susceptible to
flares.
By embracing both digital epidemiology and within-person
study design to examine OA flares, it is hoped that real-time
observations of individual episodic symptom variability can
provide insights into these phenomena and their potential
relation to short-term prognosis. However, this endeavor is not
without limitations. Major challenges of this approach are the
recruitment of individuals to a Web-based data collection
platform and timely capture of events and exposures. With no
agreed objective measurement for an OA flare, the ascertainment
of onset is reliant on participant self-report. There is also the
potential for recall bias owing to differential reporting of
exposure in the hazard and control periods. For example,
participants answering questions about potential exposures over
the last 3 days while currently experiencing a flare-up
(event-driven questionnaire) may respond differently to the
same questions when they are not experiencing a flare-up
(scheduled questionnaire). Despite this, all comparisons are
within-person, therefore eliminating time-invariant person-level
confounders by design. Conditional regression is then used to
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compare exposure status between the hazard and control periods
within the same person. Factors that do not change over time,
such as gender and genetics remain constant in all periods. In
addition, inviting participants to reflect on recent experiences
to help understand the behavior of their symptoms can be easily
integrated into patient-oriented approaches to self-management
that can occur in the community and be supported by all primary
care encounters. This study will provide empirical evidence to
help patients identify common knee OA flare triggers, provide
health care professionals with questions to identify patients at
most risk of frequent flare-ups, and inform clinical guidelines.
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